ASU hosts NASA astronaut Cady Coleman

February 22, 2012

Arizona State University’s College of Technology and Innovation will host NASA astronaut Cady Coleman (Colonel, USAF, RET.) on the ASU Polytechnic campus on March 1. Coleman joined NASA in 1992 and has since logged more than 4,330 hours in space aboard the space shuttle Columbia and the International Space Station.

“Dr. Coleman’s career is a testament to the wide range of opportunities for students who pursue Science, Technology, Engineering and Math (STEM) degrees,” said Mitzi Montoya, vice provost and dean of ASU’s College of Technology and Innovation. “This is a tremendous opportunity for current and prospective students and alumni to come meet a true Renaissance woman." Download Full Image

Coleman’s talk, “Six Months in Space onboard the International Space Station,” is a Thing on Thursday production and begins at 4 p.m., in the Cooley Ballroom on the ASU Polytechnic Campus. Doors will open at 3:30 p.m. RSVP by Feb. 27 at An Aviation Open House will follow the event, with tours available of the Del E. Webb Foundation High Altitude Chamber Lab, Ottosen Air Traffic Control Simulation Laboratory and flight simulators, from 5:15 to 6:15 pm. Prospective students can learn more about CTI’s aviation programs in professional flight, air traffic management and air transportation management.

Coleman received a Bachelor of Science degree in chemistry from the Massachusetts Institute of Technology in 1983. She joined the Air Force as a second lieutenant and continued her graduate work at the University of Massachusetts Amherst, where her research focused on polymer synthesis using the olefin metathesis reaction and polymer surface modification. 

In 1988, Coleman entered active duty and was assigned to Wright-Patterson Air Force Base. As a research chemist at the Materials Directorate of the Wright Laboratory, she synthesized model compounds for optical applications, such as advanced computers and data storage.  Coleman also acted as a surface analysis consultant for the Long Duration Exposure Facility (launched from STS-41C in 1984 and retrieved during STS-32 in 1990). Coleman retired from the Air Force in November 2009.

Coleman was selected by NASA in March 1992 and reported to the Johnson Space Center in August 1992. She served as a mission specialist on STS-73 and was the lead mission specialist on STS-93 for the deployment of the Chandra X-Ray Observatory.  On Coleman's third space mission, she served as a flight engineer aboard the Russian Soyuz TMA-20 spacecraft for launch and landing and spent 159 days in space aboard the International Space Station. In addition to performing science experiments and space station system maintenance operations, she acted as the lead robotics and science officer during her tenure aboard the ISS.  Notably, Coleman was the lead robotic arm operator for the capture of Kounatori, performing the second-ever free flyer robotic capture aboard the ISS. 

Cancer specialist von Eschenbach to present seminar at ASU

February 22, 2012

Internationally renowned cancer specialist Andrew C. von Eschenbach, who championed an agenda to modernize the U.S. Food and Drug Administration, will present a seminar March 9 at Arizona State University. Von Eschenbach’s talk, which is free and open to the public, will be held 10-11:30 a.m., in the auditorium of the Biodesign Institute at ASU, 727 E. Tyler St., Tempe.

Von Eschenbach, who has a medical degree from Georgetown University School of Medicine and a bachelor’s degree from St. Joseph’s University in his native Philadelphia, is president of Samaritan Health Initiatives and an adjunct professor at the University of Texas MD Anderson Cancer Center in Houston. Andrew C. von Eschenbach Download Full Image

The title of his talk is “The Revolution in Biology and Molecular Medicine.” It is part of a 2012 seminar series sponsored by ASU’s Complex Adaptive Systems Initiative and the Biodesign Institute.

Von Eschenbach served as commissioner of the FDA from 2005-2009 and championed an agenda to modernize the agency by process improvement of the regulatory pathway for drugs and medical devices and by fostering creative projects, including FDA’s Critical Path Initiative, which was designed to bring modern tools of science to the product development process.

Under his leadership, the FDA experienced dramatic increases in resources enabling implementation of new programs designed to strengthen the FDA in its mission to protect and promote public health. He has emphasized FDA’s role in working with external partners to assure quality throughout the entire life cycle of the products it regulates.

Before assuming the leadership role at the FDA, von Eschenbach served four years as director of the National Cancer Institute at the National Institutes of Health where he set an ambitious goal to eliminate the suffering and death due to cancer by rapid acceleration and integration of the discover-development-delivery continuum.

Von Eschenbach entered government service after a career as a physician, surgeon, oncologist and executive that included numerous leadership roles from chairman of urologic oncology to executive vice president and chief academic at the University of Texas MD Anderson Cancer Center.

He is a founding member of the National Dialogue on Cancer and has received numerous professional awards and honors. In 2006, he was named one of Time magazine’s 100 most influential people to shape the world. In both 2007 and 2008, von Eschenbach was selected as one of the Modern Healthcare/Modern Physician’s 50 most powerful physician executives in healthcare.

Additionally, von Eschenbach served as a Lt. Commander in the U.S. Navy Medical Corps.

More information is available at 480-965-0115. A map of the Biodesign Institute is at